Drug Metabolism Pharmacokinetics (DMPK) - ADME Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

Arcus Biosciences · 1 month ago

Drug Metabolism Pharmacokinetics (DMPK) - ADME Intern

Arcus Biosciences is seeking a highly motivated individual to join their Drug Metabolism and Pharmacokinetics team for a summer internship. This internship is designed to provide undergraduate and graduate students with hands-on experience in pharmaceutical Research & Development, focusing on ADME computational models.

BiopharmaBiotechnologyClinical TrialsHealth CareMedicalPharmaceuticalTherapeutics
check
H1B Sponsor Likelynote

Responsibilities

Gain hands-on experience with ADME computational modeling in a pharmaceutical R&D setting
Integrate ADME computational models into interactive web applications using Streamlit or Shiny library
Collaborate with Research Informatics team to deploy the applications on the server
Other projects as assigned

Qualification

PythonRADME conceptsStreamlitShinyAnalytical skillsProblem-solving skills

Required

Currently enrolled in a Bachelor's, Master's or PhD program in Computational Chemistry, Data Science, or related field
Proficiency in Python and/or R is required
Strong analytical and problem-solving skills

Preferred

Experience developing interactive applications using Streamlit or Shiny is a plus
Familiarity with basic ADME concepts and computational models is highly desirable

Company

Arcus Biosciences

twittertwittertwitter
company-logo
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

H1B Sponsorship

Arcus Biosciences has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (15)
2023 (18)
2022 (20)
2021 (15)
2020 (10)

Funding

Current Stage
Public Company
Total Funding
$1.52B
Key Investors
Hercules CapitalGilead SciencesGoogle Ventures
2025-10-30Post Ipo Equity· $250M
2025-02-18Post Ipo Equity· $150M
2024-08-27Post Ipo Debt· $150M

Leadership Team

leader-logo
Terry Rosen
CEO
linkedin
leader-logo
Juan Jaen
President, Co-Founder, Board of Directors
linkedin
Company data provided by crunchbase